Free Trial

Radiopharm Theranostics Limited - American Depositary Shares (RADX) Stock Forecast & Price Target

$4.18 +0.18 (+4.50%)
As of 11:41 AM Eastern

Radiopharm Theranostics Limited - American Depositary Shares - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
0
Buy
1

Based on 1 Wall Street analysts who have issued ratings for Radiopharm Theranostics Limited - American Depositary Shares in the last 12 months, the stock has a consensus rating of "Buy." Out of the 1 analysts, 1 has given a buy rating for RADX.

Consensus Price Target

$12.00
187.08% Upside
According to the 1 analysts' twelve-month price targets for Radiopharm Theranostics Limited - American Depositary Shares, the average price target is $12.00. The highest price target for RADX is $12.00, while the lowest price target for RADX is $12.00. The average price target represents a forecasted upside of 187.08% from the current price of $4.18.
Get the Latest News and Ratings for RADX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Radiopharm Theranostics Limited - American Depositary Shares and its competitors.

Sign Up

RADX Analyst Ratings Over Time

TypeCurrent Forecast
5/2/24 to 5/2/25
1 Month Ago
4/2/24 to 4/2/25
3 Months Ago
2/2/24 to 2/1/25
1 Year Ago
5/3/23 to 5/2/24
Strong Buy
0 Strong Buy rating(s)
N/A N/A N/A
Buy
1 Buy rating(s)
N/A N/A N/A
Hold
0 Hold rating(s)
N/A N/A N/A
Sell
0 Sell rating(s)
N/A N/A N/A
Consensus Price Target$12.00N/AN/AN/A
Forecasted Upside187.08% UpsideN/AN/AN/A
Consensus Rating
Buy
N/AN/AN/A

RADX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

RADX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Radiopharm Theranostics Limited - American Depositary Shares Stock vs. The Competition

TypeRadiopharm Theranostics Limited - American Depositary Shares CompaniesS&P 500
Consensus Rating Score
3.00
3.26
2.54
Consensus RatingBuyBuyModerate Buy
Predicted Upside187.08% Upside545.60% Upside18.06% Upside
News Sentiment Rating
Positive News

See Recent RADX News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/1/2025Maxim Group
3 of 5 stars
Michael Okunewitch
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$12.00+206.90%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 12:02 PM ET.


RADX Forecast - Frequently Asked Questions

According to the research reports of 1 Wall Street equities research analysts, the average twelve-month stock price forecast for Radiopharm Theranostics Limited - American Depositary Shares is $12.00, with a high forecast of $12.00 and a low forecast of $12.00.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Radiopharm Theranostics Limited - American Depositary Shares in the last year. There is currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" RADX shares.

According to analysts, Radiopharm Theranostics Limited - American Depositary Shares's stock has a predicted upside of 187.08% based on their 12-month stock forecasts.

Radiopharm Theranostics Limited - American Depositary Shares has been rated by research analysts at Maxim Group in the past 90 days.

Analysts like Radiopharm Theranostics Limited - American Depositary Shares less than other "" companies. The consensus rating score for Radiopharm Theranostics Limited - American Depositary Shares is 3.00 while the average consensus rating score for "" companies is 3.26. Learn more on how RADX compares to other companies.


This page (NASDAQ:RADX) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners